openPR Logo
Press release

Global Cyclosporine drugs Market Size, Share, Analysis, Industry Report and Forecast 2020-2026

11-23-2020 08:48 AM CET | Health & Medicine

Press release from: ORION MARKET RESEARCH

Global Cyclosporine drugs Market Size, Share, Analysis,

The global cyclosporine drugs market is anticipated to showcase considerable growth during the forecast period (2020-2026). The new product launches with rising FDA approvals are a factor contributing to the growth of the global cyclosporine drugs market. Cyclosporine drug is an immunosuppressant class of drugs that is extracted from Tolypocladium fungus which prevents side effects on the immune system such as encephalomyelitis, graft diseases, allograft rejection, delayed hypersensitivity and experimental allergy. In addition, the cyclosporine drug is used in the treatment of a broad spectrum of diseases such as dry eye syndrome, rheumatoid arthritis, and psoriasis. Neoral and Sandimmune are the available drug formulations for the oral route, and Restasis is used for ocular delivery of cyclosporine.

Request a Free Sample of our Global Cyclosporine drugs Market: https://www.omrglobal.com/request-sample/cyclosporine-drugs-market

AbbVie Inc., Allergan PLC, Apotex Inc., Eon Labs, Mayne Pharma Group Ltd. McKesson Medical-Surgical Inc., Novartis Inc., Santen Inc., Sun Pharmaceuticals, Teva Pharmaceuticals, and so on are the key players operating in the global cyclosporine drugs market. These players are actively involved in adopting different growth strategies such as mergers and acquisitions, partnerships, collaboration, and strategic agreements among others to remain competitive in the market place. New product launches and investment in the R&D is the key strategy adopted by the players of the global cyclosporine drugs market to sustain their marketplace.

For instance, in March 2019, Breath Therapeutics Inc. had announced the launch of a Ph3 trial for the inhaled liposomal cyclosporine A therapy. In August 2018, Sun Pharmaceutical Industries Ltd. had received US FDA approval for CEQUA (cyclosporine ophthalmic solution) 0.09%. CEQUA is an aqueous solution used to increase tear production in patients suffering from keratoconjunctivitis sicca (dry eye). CEQUA provides the highest FDA-approved concentration of cyclosporine A (CsA) and is based on nanomicellar technology. The innovative nanomicellar formulation used in CEQUA allows the CsA molecule to overcome the solubility challenges involved in the treatment of the dry eyes by penetrating the eye’s aqueous layer and preventing the release of the active lipophilic molecule before the actual penetration.

In May 2018, Teva Canada Ltd, a subsidiary of Teva Pharmaceutical Industries Ltd., had launched Teva-Cyclosporine ophthalmic emulsion, 0.05% w/v, a Health Canada approved twice-daily eye drop solution and the first generic version of Restasis (cyclosporine) in Canada. Cyclosporine ophthalmic emulsion is produced for the treatment of moderate to moderately severe aqueous deficient dry eye syndrome having ocular staining, reduction in tear production, and fluctuating visual symptoms.

A full Report of Global Cyclosporine drugs Market is Available at: https://www.omrglobal.com/industry-reports/cyclosporine-drugs-market
Cyclosporine Drugs Market Segmentation

By Indication

• Rheumatoid Arthritis
• Psoriasis
• Transplant Rejection Prophylaxis
• Dry Eye
• Autoimmune Myasthenia Gravis
• Other

By Route of Administration

• Oral
• Parenteral

Cyclosporine Drugs market – Segment by Region

North America
• The US
• Canada

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

Company Profiles

• AbbVie Inc.
• Allergan PLC
• Apotex, Inc.
• Mayne Pharma Group Ltd.
• Mckesson Medical Surgical Inc.
• Novartis AG
• Otsuka Pharmaceutical Co. Ltd.
• Regenerx Biopharmaceuticals, Inc.
• Santen Pharmaceuticals Co. Ltd.
• Sun Pharmaceuticals Industries, Ltd.
• Takeda Pharmaceutical Co. Ltd.
• Teva Pharmaceuticals Industries, Ltd.
• United Biotech Pvt. Ltd.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/cyclosporine-drugs-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Cyclosporine drugs Market Size, Share, Analysis, Industry Report and Forecast 2020-2026 here

News-ID: 2192877 • Views:

More Releases from ORION MARKET RESEARCH

Road Marking Paint Market : A Guide to Understanding the Process
Road Marking Paint Market : A Guide to Understanding the Process
The Road Marking Paint Market, valued at approximately USD 5.02 billion in 2023, is projected to reach around USD 7.69 billion by 2033, growing at a compound annual growth rate (CAGR) of 4.36% from 2024 to 2033. Road Marking Paint Market Overview The Road Marking Paint Market is steadily expanding, driven by burgeoning infrastructure investments and the need for improved road safety. Governments and municipalities are increasingly allocating funds toward both new
Outboard Boat Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Outboard Boat Market Size Analysis, Competitive Insights, Leading Players and Gr …
The Outboard Boats Market, valued at approximately USD 5.74 billion in 2023, is projected to grow to around USD 14 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 9% over the 2024-2033 period. Outboard Boat Market Overview The Outboard Boat Market continues to expand robustly, fueled largely by rising demand for recreational boating, favorable economic conditions, and the appeal of leisure marine activities. Innovations in outboard motor technology-including
Mobile Ticketing Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Mobile Ticketing Market Size Analysis, Competitive Insights, Leading Players and …
The Mobile Ticketing Market, valued at about USD 2.9 billion in 2023, is anticipated to grow to approximately USD 11.39 billion by 2033, reflecting a robust CAGR of 16.7% from 2024 to 2033. Mobile Ticketing Market Overview The Mobile Ticketing Market is undergoing rapid expansion, driven primarily by the global surge in smartphone usage and consumer preference for contactless, digital experiences. This growth is further propelled by widespread adoption of digital payments,
Metal Alloy Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Metal Alloy Market Size Analysis, Competitive Insights, Leading Players and Grow …
The Metal Alloy Market, valued at approximately USD 301.7 billion in 2023, is projected to reach USD 533.9 billion by 2033, growing at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2033. Metal Alloy Market Overview The Metal Alloy Market is experiencing steady, long-term expansion, driven by growing demand from key sectors such as automotive, aerospace, construction, and electronics. Applications in next-generation vehicles and aircraft are pushing interest in

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the